- Efficacy and Safety of FOLFIRI as Second-line Chemotherapy in Advanced Gastric Cancer
-
Park SC, Chun HJ
- KMID: 2373304
- Korean J Gastroenterol.
- 2015 Jul;66(1):1-4.
- doi: 10.4166/kjg.2015.66.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Second Line Chemotherapy for Pancreatic Cancer
-
Park JY
- KMID: 1718400
- Korean J Gastroenterol.
- 2011 Apr;57(4):207-212.
- doi: 10.4166/kjg.2011.57.4.207
Pancreatic cancer is a very lethal cancer. It is the 5th most common cause for cancer related mortality in Korea. Most of patients have unresectable pancreatic cancer, and systemic chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Adenocarcinoma with Focal Choriocarcinomatous Differentiation in the Sigmoid Colon
-
Oh SK, Kim HW, Kang DH, Choi CW, Choi YY, Lim HK, Goo JJ, Choi SY
- KMID: 2373360
- Korean J Gastroenterol.
- 2015 Nov;66(5):291-296.
- doi: 10.4166/kjg.2015.66.5.291
Primary colorectal choriocarcinoma is a rare neoplasm. Only 19 cases have been reported worldwide, most of which involved adenocarcinomas. The prognosis is usually poor, and the standard therapy for this... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors for Metastatic Colorectal Cancer after First-line Chemotherapy with FOLFOX-4 or FOLFIRI Regimen
-
Kim JH, Choi PR, Park SJ, Park MI, Moon W, Kim SE, Lee GW
- KMID: 1791877
- Korean J Gastroenterol.
- 2014 Apr;63(4):209-215.
- doi: 10.4166/kjg.2014.63.4.209
BACKGROUND/AIMS: Information on prognostic factors for metastatic colorectal cancer is an important basis for planning the treatment and predicting the outcomes of the patients; however, it has not been well... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Carcinoembryonic Antigen for Monitoring Tumor Progression during Palliative Chemotherapy in Metastatic Colorectal Cancer
-
Kim G, Jung EJ, Ryu CG, Hwang DY
- KMID: 1776926
- Yonsei Med J.
- 2013 Jan;54(1):116-122.
- doi: 10.3349/ymj.2013.54.1.116
PURPOSE: To evaluate the efficacy of carcinoembryonic antigen (CEA) measurement for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer. MATERIALS AND METHODS: Forty-eight patients with initially unresectable metastatic colorectal... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy for Colorectal Cancer
-
Hong YS, Kim TW
- KMID: 1775934
- Korean J Gastroenterol.
- 2009 Dec;54(6):355-363.
- doi: 10.4166/kjg.2009.54.6.355
Recent advances in chemotherapy lead to improved survival outcomes in patients with colorectal cancer. The 5-fluorouracil (5-FU) is still one of the important chemotherapeutic agents since 1950s, but the introduction... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
-
Kang SH, Kim JI, Moon HS, Kim SH, Sung JK, Lee BS, Jeong HY
- KMID: 1775923
- Korean J Gastroenterol.
- 2010 Jan;55(1):26-32.
- doi: 10.4166/kjg.2010.55.1.26
BACKGROUND/AIMS: We performed retrospective study in order to compare oxaliplatin, leucovorin, and fluorouracil (FOLFOX) versus irinotecan, leucovorin, and fluorouracil (FOLFIRI) in recurred or metastatic gastric adenocarcinoma. METHODS: We investigated 56 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Toxicities and Efficacies of the Combination Chemotherapy Regimens in Advanced Gastric Cancer Patients Who Achieved Complete Response after Chemotherapy
-
Kim YJ, Goh PG, Kim ES, Lee SY, Moon HS, Lee ES, Sung JK, Kim SH, Lee BS, Jeong HY
- KMID: 1043329
- Korean J Gastroenterol.
- 2011 Dec;58(6):311-317.
- doi: 10.4166/kjg.2011.58.6.311
BACKGROUND/AIMS: We retrospectively analyzed comparative toxicities and efficacies of chemotherapy regimens in advanced gastric cancer (AGC) patients who achieved complete response (CR) after chemotherapy. METHODS: We reviewed the medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
